Home > Boards > US Listed > Biotechs > Ionis Pharmaceuticals Inc. (IONS)

So our new drug that gives a

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
shub Member Profile
 
Followed By 12
Posts 1,387
Boards Moderated 0
Alias Born 04/12/11
160x600 placeholder
Ionis to hold third quarter 2021 financial results webcast PR Newswire (US) - 10/20/2021 7:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/19/2021 6:30:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/19/2021 6:30:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/19/2021 6:29:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/18/2021 2:31:51 PM
Ionis Pharma Shares Drop 12% After Tofersen Study Misses Primary Endpoint Dow Jones News - 10/18/2021 10:55:00 AM
Ionis' partner Biogen provides update on tofersen Phase 3 VALOR study in SOD1-ALS PR Newswire (US) - 10/17/2021 4:20:00 PM
Topline Results from Tofersen Phase 3 Study and its Open Label Extension in SOD1-ALS to be Presented at the American Neurological Association Annual Meeting GlobeNewswire Inc. - 10/14/2021 4:06:00 PM
VC Daily: Expansion Therapeutics Gets $80 Million for RNA-Targeted Drugs Dow Jones News - 9/30/2021 10:54:00 AM
PTC Therapeutics slips after early stage results from Huntington's disease trial Seeking Alpha - 9/23/2021 3:34:23 PM
Biogen Plans to Initiate Phase 3b Study Evaluating Potential Benefit of a Higher Dose of Nusinersen in Patients Previously Treated with Evrysdi® (risdiplam) GlobeNewswire Inc. - 9/15/2021 7:30:00 AM
Ionis to host ATTR symposium highlighting CARDIO-TTRansform Study at 3rd European ATTR Amyloidosis meeting PR Newswire (US) - 9/3/2021 7:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2021 7:26:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2021 7:21:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2021 7:21:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2021 7:21:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2021 7:21:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2021 7:20:54 PM
Ionis to present at upcoming virtual investor conferences PR Newswire (US) - 9/2/2021 7:05:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/5/2021 5:00:08 PM
Ionis Pharmaceuticals EPS in-line, misses on revenue Seeking Alpha - 8/4/2021 7:04:07 AM
Ionis reports second quarter 2021 financial results and recent business achievements PR Newswire (US) - 8/4/2021 7:00:00 AM
Ionis provides enrollment update for Novartis' late-stage pelacarsen study Seeking Alpha - 8/2/2021 10:14:13 AM
Lp(a) HORIZON achieves 50% enrollment in trial to assess the safety and efficacy of pelacarsen in reducing recurrent cardiovascular events PR Newswire (US) - 8/2/2021 9:30:00 AM
Ionis completes enrollment in late-stage eplontersen polyneuropathy study Seeking Alpha - 7/29/2021 7:47:31 AM
shub   Tuesday, 10/24/17 03:05:30 PM
Re: None
Post # of 485 
So our new drug that gives a small population of doomed children a chance at life, only sold about as many doses as last quarter.
Everyone knew it was a small patient population and another important test of the success of our anti-sense platform.
As a reward, the SP plummets 10%!..A genuinely chicken-ship reaction from the market

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences